4-Hydroxypiperidines and their flexible 3-(amino)propyloxy analogues as non-imidazole histamine H3 receptor antagonist

Autor: Daniel McNaught Flores, Wiesława Agnieszka Fogel, Rob Leurs, Krzysztof Walczyński, Beata Olszewska, Anna Stasiak
Přispěvatelé: AIMMS, Medicinal chemistry
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Male
0301 basic medicine
N-methyl-5-{[1-(ω-substitutedalkyl)piperidin-4-yl]oxy}-N-propylpentan-1-amines
Guinea Pigs
histamine H3 receptor non-imidazole antagonists
Pharmacology
Article
Catalysis
lcsh:Chemistry
Inorganic Chemistry
Structure-Activity Relationship
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Piperidines
In vivo
5-{3-[ω-substitutedalkyl](methyl)aminopropoxy}-N-methyl-N-propylpentan-1-amines
Ciproxifan
medicine
Animals
Humans
Receptors
Histamine H3

Inverse agonist
Rats
Wistar

Physical and Theoretical Chemistry
Neurotransmitter
lcsh:QH301-705.5
Molecular Biology
Spectroscopy
Amination
Thioperamide
Organic Chemistry
Antagonist
N-methyl-5-{[1-(ω-substitutedalkyl) piperidin-4-yl]oxy}-N-propylpentan-1-amines
General Medicine
Rats
Computer Science Applications
HEK293 Cells
030104 developmental biology
lcsh:Biology (General)
lcsh:QD1-999
chemistry
Histamine H3 receptor
Histamine H receptor non-imidazole antagonists
030217 neurology & neurosurgery
Histamine
Histamine H3 Antagonists
medicine.drug
Zdroj: International Journal of Molecular Sciences; Volume 19; Issue 4; Pages: 1243
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 19:1243, 1-19. Multidisciplinary Digital Publishing Institute (MDPI)
Olszewska, B, Stasiak, A, McNaught Flores, D, Fogel, W A, Leurs, R & Walczyński, K 2018, ' 4-Hydroxypiperidines and their flexible 3-(amino)propyloxy analogues as non-imidazole histamine H 3 receptor antagonist : Further structure-activity relationship exploration and in vitro and in vivo pharmacological evaluation ', International Journal of Molecular Sciences, vol. 19, 1243, pp. 1-19 . https://doi.org/10.3390/ijms19041243
International Journal of Molecular Sciences, Vol 19, Iss 4, p 1243 (2018)
ISSN: 1661-6596
DOI: 10.3390/ijms19041243
Popis: Presynaptic histamine H3 receptors (H3R) act as auto- or heteroreceptors controlling, respectively, the release of histamine and of other neurotransmitters in the central nervous system (CNS). The extracellular levels of several neurotransmitters are enhanced by H3R antagonists, and there is a great interest for potent, brain-penetrating H3 receptor antagonists/inverse agonists to compensate for the neurotransmitter deficits present in various neurological disorders. We have shown that 1-[(benzylfuran-2-yl)methyl]piperidinyl-4-oxyl- and benzyl- derivatives of N-propylpentan-1-amines exhibit high in vitro potencies toward the guinea pig H3 receptor (jejunum), with pA2 = 8.47 and 7.79, respectively (the reference compound used was thioperamide with pA2 = 8.67). Furthermore, following the replacement of 4-hydroxypiperidine with a 3-(methylamino)propyloxy chain, the pA2 value for the first group decreased, whereas it increased for the second group. Here, we present data on the impact of elongating the aliphatic chain between the nitrogen of 4-hydroxypiperidine or 3-(methylamino)propan-1-ol and the lipophilic residue. Additionally, the most active compound in this series of non-imidazole H3 receptor antagonists/inverse agonists, i.e., ADS-003, was evaluated for its affinity to the recombinant rat and human histamine H3 receptors transiently expressed in HEK-293T cells. It was shown that ADS-003, given parenterally for 5 days, reduced the food intake of rats, as well as changed histamine and noradrenaline concentrations in the rats’ brain in a manner and degree similar to the reference H3 antagonist Ciproxifan.
Databáze: OpenAIRE